Overview
The purpose of the study is to assess the efficacy of the SpyGlass DS for the detection of residual pancreatic calculations after endoscopic treatment.
Eligibility
Inclusion Criteria:
- aged 18 and over;
- with chronic calcifying pancreatitis;
- having already received endoscopic treatment for pancreatic pain related to stenosis and / or pancreatic stones;
- having given free, informed and written consent;
- being affiliated to a social security scheme or beneficiary of such a scheme.
Exclusion Criteria:
- contraindications to performing an upper digestive endoscopy;
- haemorrhagic disease, haemostasis and coagulation disorder (PR <60%, PTT> 40 s and platelets <60,000 / mm3;
- pregnant or breastfeeding woman;
- adult patient protected (guardianship or curatorship), or deprived of liberty by a judicial or administrative decision;
- person subject to a safeguard measure.